2021 International Summit on Chemical Reactions and Pharmaceutical Processes Opens for Registration
The global biopharmaceutical industry is undergoing dynamic transformation, driven by an international perspective and technological innovation. How to leverage the advantages of cutting-edge academic research, deepen open collaboration, stimulate innovation within the pharmaceutical industry, and reduce costs across the entire lifecycle from R&D to market launch is not only a critical issue for the development of the global pharmaceutical industry, but also holds significant importance for sustainable development and improving the quality of human life.
Seizing the opportunity presented by the national emphasis on basic research and industry-academia-research collaboration, the Chinese Chemical Society approved the establishment of the Process Chemistry Committee in spring 2021, with Academician Ma Dawei from the Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, serving as its inaugural chair. The committee is dedicated to exploring the development directions, challenges, and “chokehold” issues facing China’s pharmaceutical, agrochemical, and fine chemical industries, promoting the translation of original basic research achievements into practical applications, and facilitating the industrial upgrading of these sectors in China.
Focusing on cutting-edge technologies and exploring innovative methods. The “International Summit Forum on New Technologies, New Methods, and Green Pharmaceutical Processes, as well as Chemical Reactions and Pharmaceutical Processes in 2021,” hosted by the Organic Reactions and Processes Branch of the Chinese Chemical Society and organized by Nankai University and Asymchem Laboratories (Tianjin) Co., Ltd., will be held in Tianjin, China, from September 17 to 18, 2021.
Technological advancements and industrial development in the biopharmaceutical sector are long-term processes that require substantial investment of capital and talent, as well as deep integration and coordinated efforts across the industrial, innovation, talent, funding, and policy chains. As a premier conference garnering significant attention from both academia and industry, the International Summit Forum on Chemical Reactions and Pharmaceutical Processes has been successfully held for four consecutive sessions. The forum invites numerous scholars and experts from domestic and international universities, along with senior industry specialists, to attend and deliver presentations, attracting hundreds of researchers for academic exchange. It focuses on discussing the latest progress and development trends in organic synthesis, biosynthesis, medicinal chemistry, catalysis, and technological innovation, while addressing critical bottlenecks facing the contemporary pharmaceutical industry. By sharing successful experiences in drug research and development, the forum aims to contribute to the advancement of China’s pharmaceutical industry and accelerate the market launch of more innovative drugs with clinical value.
Institute Professor of Chemistry at the Massachusetts Institute of Technology; Member of the American Academy of Arts and Sciences; Member of the U.S. National Academy of Sciences. Recipient of the Arthur C. Cope Award (2013), Linus Pauling Award (2014), William H. Nichols Medal (2016), Roger Adams Award in Chemistry (2018), and Wolf Prize in Chemistry (2019).Professor at The Scripps Research Institute; Member of the American Academy of Arts and Sciences. Recipient of the Arthur C. Cope Scholar Award (2012), Elias J. Corey Award (2014), MacArthur Fellowship (2016), and the Royal Society of Chemistry Pedler Award (2017).
Chief Professor in the Department of Chemistry at the Massachusetts Institute of Technology; Member of the American Academy of Arts and Sciences; Member of the U.S. National Academy of Sciences. Author of 490 published papers and holder of 47 granted patents. Recipient of the 2000 Organometallic Chemistry Award from the American Chemical Society (ACS) and the MERIT Award from the National Institutes of Health (NIH). Honored with the 2005 Bristol-Myers Squibb Distinguished Achievement Award, the CAS SciFinder Scholar Award, the ACS Award for Creative Work in Synthetic Organic Chemistry, and the Siegfried Medal for Chemical Methods. Received the 2010 Gustavus J. Esselen Award for Industry in the Public Interest from the ACS. Awarded the 2013 Arthur C. Cope Award by the ACS. Recipient of the 2014 Linus Pauling Medal and the Ulysses Medal from University College Dublin. Granted an honorary doctorate from the University of South Florida in 2015 and awarded the BBVA Foundation Frontiers of Knowledge Award in Basic Sciences (2014 award cycle). Selected as the 2016 recipient of the William H. Nichols Medal and the 2018 Roger Adams Award in Organic Chemistry.
